Cullinan Therapeutics, Inc.

CGEM

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001789972

SEC filings (opens in a new tab)

In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Cullinan Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of CGEM: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	113	1	135	+23
Shares	39.4M	45.8K	62.9M	+23.6M (+60.0%)
Value	$670.8M	$779.7K	$1.10B	+$427.3M (+63.8%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (39)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to CGEM in Q2 2024
Institution	Shares	Value	% of portfolio
Avidity Partners Management LP	1,559,826	$27.2M	1.16%
VR Adviser, LLC	1,379,965	$24.1M	1.53%
Holocene Advisors, LP	1,316,005	$23.0M	0.10%
Cormorant Asset Management, LP	1,125,000	$19.6M	1.14%
Artal Group S.A.	1,057,949	$18.5M	0.47%
RTW Investments, LP	1,052,630	$18.4M	0.28%
Perceptive Advisors LLC	749,916	$13.1M	0.32%
Rock Springs Capital Management LP	658,338	$11.5M	0.35%
Foresite Capital Management V, LLC	657,905	$11.5M	7.33%
Boxer Capital, LLC	657,895	$11.5M	0.60%
Twin Focus Capital Partners, LLC	595,489	$10.4M	1.66%
Lynx1 Capital Management LP	377,323	$6.58M	2.37%
CenterBook Partners LP	341,262	$5.95M	0.37%
Voloridge Investment Management, LLC	163,047	$2.84M	0.01%
Balyasny Asset Management LLC	150,708	$2.63M	0.01%
Ensign Peak Advisors, Inc	148,773	$2.59M	0.00%
Assenagon Asset Management S.A.	114,195	$1.99M	0.00%
Jacobs Levy Equity Management, Inc	98,296	$1.71M	0.01%
Walleye Capital LLC	92,869	$1.62M	0.02%
E Fund Management Co., Ltd.	74,827	$1.30M	0.07%
UBS Asset Management Americas Inc	68,534	$1.20M	0.00%
Two Sigma Investments, LP	57,361	$1.00M	0.00%
ADAR1 Capital Management, LLC	53,261	$928.9K	0.19%
Russell Investments Group, Ltd.	34,293	$598.1K	0.00%
Sherbrooke Park Advisers LLC	25,976	$453.0K	0.08%
Corebridge Financial, Inc.	20,796	$362.7K	0.00%
Janus Henderson Group PLC	18,528	$322.7K	0.00%
Y-Intercept (Hong Kong) Ltd	18,026	$314.4K	0.02%
Mirae Asset Global ETFs Holdings Ltd.	16,956	$294.3K	0.00%
Mariner, LLC	16,354	$285.2K	0.00%
Voya Investment Management LLC	12,969	$226.2K	0.00%
Alpine Global Management, LLC	12,164	$212.1K	0.04%
Squarepoint Ops LLC	10,669	$186.1K	0.00%
Arizona State Retirement System	10,460	$182.4K	0.00%
Public Employees Retirement System of Ohio	2,847	$49.7K	0.00%
Advisor Group Holdings, Inc.	50	$872	0.00%
Rothschild Investment LLC	25	$436	0.00%
SRS Capital Advisors, Inc.	7	$123	0.00%
Covestor Ltd	5	$0	0.00%

Sold out (16)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of CGEM in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Logos Global Management LP	700,000	$11.9M
Rubric Capital Management LP	626,929	$10.7M
Parkman Healthcare Partners LLC	178,396	$3.04M
Kennedy Capital Management, Inc.	84,234	$1.44M
Schonfeld Strategic Advisors LLC	60,074	$1.02M
Cubist Systematic Strategies, LLC	55,888	$952.3K
Connor, Clark & Lunn Investment Management Ltd.	36,401	$620.3K
New York Life Investment Management LLC	21,250	$362.1K
Prudential Financial Inc	20,225	$344.6K
ExodusPoint Capital Management, LP	16,347	$279.0K
American International Group, Inc.	12,742	$217.1K
Metropolitan Life Insurance Co	1,286	$21.9K
Point72 (DIFC) Ltd	1,273	$21.7K
GWM Advisors LLC	723	$12.3K
Simplex Trading, LLC	119	$2.00K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	5	$85

Not filed for Q2 2024 yet (1)

Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CGEM in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	45,755	$779.7K